Gene Therapy, RNA, Cancer Vaccines & OV Drug Development | Advance Therapeutics | Competitive & Scientific Intelligence
🔬 Exciting Developments in OV Drug Landscape! 🔬 In just the first few months of 2024, we've witnessed 30 new OV drugs disclosed and 14 new trials initiated. Navigating this dynamic landscape can be daunting, but strategic decision-making backed by comprehensive data can significantly mitigate risks and potential failures as you enter the clinic. Curious about what 2023 brought to the table? Dive into our comprehensive landscape review utilizing data from our OV-dedicated database below 👇 If you are currently developing OV drugs, drop me a message. I'm here to provide tailored insights to help accelerate your drug development. #oncolyticviruses #drugdevelopment
Unlock the 2023 Oncolytic Viruses Drug Landscape! Get your copy for a comprehensive review of 2023 by viral family and an analysis of discontinued assets. Discover how the Rhabdoviridae family has defied expectations, emerging as the fastest-growing group. Access now https://ter.li/ywglm5